Keywords
hemodialysis
natural disasters
pandemic
quarantine
How to Cite
Abstract
Peritoneal Dialysis is a therapy equal to or superior to hemodialysis, it is cost-effective and has allowed vital dialysis support to populations that have been victims of natural disasters. In the current circumstances of pandemic and social isolation because of COVID 19, peritoneal dialysis, being a home therapy, reduces the risks of exposure for patients, caregivers, and care teams, however, it is a globally underused therapy. We would like to show the benefits of peritoneal dialysis over hemodialysis and its outcomes in times of disaster, presenting it as the best alternative even in times of pandemic. A non-systematic review of the literature was done, looking for the benefits of peritoneal dialysis vs. hemodialysis and its outcomes in calamity situations. Here we included 75 articles that were published between 1993 and March 2020 were included. These studies show the multiple benefits of peritoneal dialysis over hemodialysis and being the best alternative in disaster situations. So we conclude that peritoneal dialysis has significant benefits over hemodialysis, among these is a greater probability of survival, particularly in the first two years, a lower speed in the rate of loss of residual renal function, allows to preserve vascular accesses, there is greater possibility of post-transplant survival. In addition to being more economical and in situations of natural disasters, such as this pandemic, it has facilitated the continuity of care and acute or chronic dialysis support for victims.
References
Volume 2: ESRD In theUnited States. In: US Renal Data System 2018 Annual Data Re-port. Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2019 [cita-do diciembre 29 2020];73(3 Suppl 1). Disponible en: https://www.sciencedirect.com/journal/american-journal-of-kidney-diseases/vol/73/issue/3/suppl/S1
International Diabetes Federation. Atlas de la diabetes de la FID .9° ed. Federación Internacional de Diabetes; 2019 [citado diciembre 29 2020]. Disponible en: https://www.diabetesatlas.org/upload/resources/material/202003021333522406-IDF-ATLAS-SPAN-BOOK.pdf
Roberts M, Polkinghorne K, McDonald S, Ierino F. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Am J Kidney Dis 2011;58:64–72
Wang A, Brimble K, Brunier G, Holt S, Jha V, Johnson D, et al. ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int 2015; 35:379–387
Andreu D, Hidalgo Miguel, Moreno Maria. La supervivencia de las personas sometidas a diálisis. EnfermNefrol [Internet]. 2013 Dic [citado 2020 Mar 27]; 16( 4 ): 278-280. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S225428842013000400009&lng=es
Pinares-Astete F, Meneses-Liendo V, Bonilla-Palacios J, Ángeles-Tacchino P, Cieza-Zevallo J. Supervivencia a largo plazo en pacientes con enfermedad renal crónica estadio 5 tratada por hemodiálisis en Lima, Perú. Acta MedPeru. 2018;35(1):20-7
Pérez M, Herrera N, Pérez E. Comportamiento de la mortalidad del adulto en hemodiálisis crónica. Rev. Arch Med Camagüey 2017;21:773-786
Krediet R, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol 2012;6:451–460
Ronco C. The Rise of Expanded Hemodialysis. Blood Purif 2017;44:I–VIII
Marshall M, Polkinghorne K, Kerr P, Agar J. Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. Am J KidneyDis. 2015;66(3):489-498
Fondo Colombiano de Enfermedades de Alto Costo. Situación de la enfermedad renalcrónica, la hipertensión arterial y la diabetes mellitus en Colombia. Bogotá D.C.: Cuenta deAlto Costo; 2018
Karopadi AN, Mason G, Rettore E, Ronco C. Cost of peritoneal dialysis and haemodialysis across the world. Nephrol DialTransplant 2013; 28: 2553–2569 https://dx.doi.org/10.1093/ndt/gft214
Centro para el Control y la Prevención de Enfermedades (CDC). COVID-19. Pregun-tas frecuentes. CDC; 2020 [citado diciembre 29 2020]. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/faq-sp.html
World Health Organization (WHO). Considerations for quarantine of individuals in thecontext of containment for coronavirus disease (COVID-19): interim guidance, 19 March2020. Ginebra: WHO; 2020 [citado marzo 14 2021]. Disponible en: https://apps.who.int/iris/handle/10665/331497
Centro para el Control y la Prevención de Enfermedades (CDC). COVID-19. Formas enlas que se propaga el COVID-19. CDC; 2020 [citado diciembre 29 2020]. Disponible en:https://www.cdc.gov/coronavirus/2019-ncov/about/transmission-sp.html
Michel JD. Covid-19:Fin de partie?!Anthropo-ogiques; 2020 [cita do diciembre 26 2020]. Disponible en: http://jdmichel.blog.tdg.ch/archive/2020/03/18/covid-19-fin-de-partie-305096.html?fbclid=IwAR2yYZeL3rUa0GyQjpxKZLnGtDHKll3VHMvFetVmZfDTZUjHUUbJoUNktg
Koo JR, Cook AR, Park M, Sun Y, Sun H, Tao Lim J, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis 2020. Published Online March 23, 2020 https://doi.org/10.1016/S14733099(20)30162-6
Servicios de Salud y Sociales de Delaware. Aislamiento y cuarentena. 2020 [citado diciem-bre 26 2020]. Disponible en: https://www.dhss.delaware.gov/dhss/dph/files/isolandquarpisp.pdf
Naicker S, Yang Ch, Hwang S, Liu B, Chen J and Jha V. The Novel Coronavirus 2019 Epidemic and Kidneys, Kidney International (2020), doi: https://doi.org/10.1016/j.kint.2020.03.001
Guan W, Ni Z, Hu Y, Liang W, Ou Ch, He J. et al. He et al. Clinical Characteristics of Coronavirus Disease 2019 in China. https://www.nejm.org/doi/pdf/10.1056/NEJMoa2002032
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L,et al. Kidney impairment isassociated with in-hospital death of patients COVID-19. Kidney Int. 2020;97(5):829-38.https://doi.org/10.1101/2020.02.18.20023242
KDIGO 2012 clinical practice guideline for the evaluation and management of chronickidney disease. Kidney Int Suppl. 2013;3(1):1-150.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382:260-272. https://doi.org/10.1016/S0140-6736(13)60687-X
Ma Y, Diao B, Lv X, Zhu J, Liang W, Liu L,et al.2019 novel coronavirus disease in he-modialysis (HD) patients: Report from one HD center in Wuhan, China. MedRxiv. 2020.https://doi.org/10.1101/2020.02.24.20027201
Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX et al. Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities. Am J Kidney Dis. 2018 Mar;71:344-351 https://doi.org/10.1053/j.ajkd.2017.08.028
Sanabria M, Muñoz J, Trillos C, Hernández G, Latorre C, Díaz CS, et al. Dialysis outcomes in Colombia (DOC) study: A comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia Kidney Int 2008; 73: S165–S172 https://doi.org/10.1038/sj.ki.5002619
Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568-3575. https://doi.org/10.1093/ndt/gfr674
Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011;171:110–118 https://doi.org/10.1001/archinternmed.2010.352
Marshall M. The benet of early survival on PD versus HD—why this is (still) very impor-tant. Perit Dial Int. 2020;40(4):405-18. https://doi.org/10.1177/0896860819895177
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic Kidney Diseaseand the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med.2004;351(13):1296-305. https://doi.org/10.1056/NEJMoa041031
Bargman J M, Thorpe K E and Churchill D N. Relative Contribution of Residual Renal Function and Peritoneal Clearance to Adequacy of Dialysis: A Reanalysis of the CANUSA Study. J Am Soc Nephrol 2001; 12:2158-2162
Paniagua R, Amato D, Vonesh E, Correa Rotter R, Ramos A, Moran J et al. Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial. J Am Soc Nephrol. 2002; 13:1307-1320
Marrón B, Remón C, Pérez-Fontán M, Quirós P, Ortíz A. Benefits of preserving residual renal function in peritoneal dialysis. Kidney Int 2008; 73: S42–S51 https://doi.org/10.1038/sj.ki.5002600
Rottembourg J, Issad B, Gallego JL, Degoulet P, Aime F, Gueffaf B et al. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis. Proc EDTA 1983; 19: 397–403.
Lysaght MJ, Vonesh EF, Gotch F, Ibels L, Keen M, Lindholm B, et al. The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 1991; 37: 598–604.
Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA,et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556–564.
Misra M, Vonesh E, Van Stone J, Moore H, Prowant B, Nolph K. Effect of cause and time of dropout on the residual GFR: a comparative analysis of the decline of GFR on dialysis. Kidney Int 2001; 59: 754–763. https://doi.org/10.1046/j.1523-%201755.2001.059002754.x
Lang S, Bergner A, Töpfer M, Schiffl H. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors. Perit Dial Int 2001; 21: 52–57.
Jansen M, Hart A, Korevaar J, Dekker F, Boeschoten E, Krediet R; NECOSAD Study Group. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046–1053 https://doi.org/10.1046/j.1523-1755.2002.00505.x
He L, Liu X, Li Z, Abreu Z, Malavade T, Lok CE, et al. Rate of decline of residual kindney function before and after the start of the peritoneal dialysis. Perit Dial Int 2016; 36(3):334–339 https://doi.org/10.3747/pdi.2016.00024
Van Biesen W, Dequidt C, Vanholder R, LameireN.. The impact of healthy start peritoneal dialysis on the evolution of residual renal function and nutrition parameters. Adv Perit Dial 2002; 18: 44–48
Berlanga J, Marrón B, Reyero A, Caramelo C, Ortiz A. Peritoneal dialysis retardation of progression of advanced renal failure. Perit Dial Int 2002; 22: 239–242.
Viglino G, Neri L, and Barbieri S. Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy. Kidney Int. 2008; 73: S52–S55 https://doi.org/10.1038/sj.ki.5002601
Pastan S, Soucie J, McClellan W. Vascular access and increased risk of death among hemodialysis patients. Kidney Int. 2002;62(2):620-626 https://doi.org/10.1046/j.1523-1755.2002.00460.x
Ethier J, Mendelssohn D, Elder S, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2008;23:3219-3226 https://doi.org/10.1093/ndt/gfn261
Perl J, Wald R, McFarlane P, Bargman J M. Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival. J Am Soc Nephrol. 2011;22:1113-1121 https://doi.org/10.1681/ASN.2010111155
Coentrão L, Santos-Araújo C, Dias C, Neto R, Pestana M. Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study. BMC Nephrol 2012; 13: 88. https://doi.org/10.1186/1471-2369-13-88
Kumar V, Sidell M, Jones J, Vonesh E. Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system. Kidney Int 2014; 86(5): 1016–1022. https://doi.org/10.1038/ki.2014.224
Heaf J, Løkkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002;17:112-117 https://doi.org/10.1093/ndt/17.1.112
Molnar M, Mehrotra R, Duong U, Bunnapradist S, Lukowsky L, Krishnan M et al Dialysis Modality and Outcomes in Kidney Transplant Recipients. Clin J Am Soc Nephrol 2012;7: 332–341 https://doi.org/10.2215/CJN.07110711
Schwenger V, Döhler B, Morath C, Zeier M, Opelz G. The role of pretransplant dialysis modality on renal allograft outcome. Nephrol Dial Transplant 2011; 26: 3761–3766 https://doi.org/10.1093/ndt/gfr132
Arrieta J. Evaluación económica del tratamiento sustitutivo renal (hemodiálisis, diálisis peritoneal y trasplante) en España. Nefrologia 2010;1(Supl Ext 1):37-47. https://doi.org/10.3265/SuplementoExtraordinario.pre2010.Jan.10127
Pacheco A, Saffie A, Torres R, Tortella C, Cristian Llanos Ll, Vargas D, et al. Cost/utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int 2007; 27:359–363
Baboolal K, McEwan P, Sondhi S, Spiewanowsk P. The cost of renal dialysis in a UK setting—a multicentre study. Nephrol Dial Transplant 2008; 23: 1982–1989 https://doi.org/10.1093/ndt/gfm870
Arrieta J, Rodríguez-Carmona A, Remón C, Pérez-Fontán M, Ortega F. Sánchez Tornero J et al. La diálisis peritoneal es la mejor alternativa coste-efectiva para la sostenibilidad del tratamiento con diálisis. Nefrologia 2011;31:505-13
Mendes M, Walker D, Sesso R, and Ferraz M . A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in São Paulo, Brazil. Perit Dial Int 2013; 33(3):304-315
Chui B, Manns B, Pannu N, Dong J, Wiebe N, Jindal K, et al. Health Care Costs of Peritoneal Dialysis Technique Failure and Dialysis Modality Switching. Am J Kidney Dis. 2012; 61:104-111 https://doi.org/10.1053/j.ajkd.2012.07.010
Klarenbach S, Tonelli M, Chui B, Manns B. Economic evaluation of dialysis therapies. Nat Rev Nephrol. 2014; 10:644-52 https://doi.org/10.1038/nrneph.2014.145
Rubin H, Fink N, Plantinga L, Sadler J, Kliger A, Powe N. Patient Ratings of Dialysis Care With Peritoneal Dialysis vs Hemodialysis JAMA. 2004;291(6):697-703 https://doi.org/10.1001/jama.291.6.697
Mapes D, Lopes A, Satayathum S, McCullough K, Goodkin D, Locatelli F et al. Health-related quality of life as a predictor of mortality and hospitalization: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Int. 2003 Jul;64(1):339-49 https://doi.org/10.1046/j.1523-1755.2003.00072.x
The World Bank, Natural Hazards, UnNatural Disasters The Economics of Effective Prevention, 2010 The International Bank for Reconstruction and Development / The World Bank 1818 H Street NW Washington DC 20433 www.worldbank.org
Pavlovic D, Jankovic N, Orlic L, Heinrich B. Dialysis patients: vulnerable group of patients, Kidney Int. 2010;77: 72; https://doi.org/10.1038/ki.2009.361
Cala S. Peritoneal dialysis in Croatia. Perit Dial Int. 2007;27:238-244.
Sanabria M, Devia M, Hernández G, Astudillo K, Trillos C, Uribe M et al; Outcomes of a Peritoneal Dialysis Program in Remote Communities Within Colombia Perit Dial Int. 2015 Jan-Feb; 35(1): 52–61 https://doi.org/10.3747/pdi.2012.00301
Ronco C, Crepaldi C, Rosner MH. Remote Patient Management in Peritoneal Dialysis. ContribNephrol. Basel, Karger, 2019, vol 197, pp 73–83 https://doi.org/10.1159/000496318
Bunch A, Vesga JI, Camargo D, Corzo L, Molano A, Devia M et al. Remote Automated Peritoneal Dialysis Management in Colombia Kidney Int Rep. 2019 Jun; 4(6): 873–876. https://doi.org/10.1016/j.ekir.2019.03.017
Nangaku M, Akizawa T; Diary of a Japanese nephrologist during the present disaster, Kidney Int. 2011;79: 1037–1039. https://dx.doi.org/10.1038/ki.2011.106
Kawabata C1, Hamanoue S2, Maekawa A2, Toyoda M2, Miyata A2, Uekihara S2., Communication with Peritoneal Dialysis Patients Post-Kumamoto Earthquake, Perit Dial Int. 2017 Jul-Aug;37(4):484-485 https://dx.doi.org/10.3747/pdi.2016.00310
Ozener C1, Ozdemir D, Bihorac A. The impact of the earthquake in northwestern Turkey on the continuous ambulatory peritoneal dialysis patients who were living in the earthquake zone, Adv Perit Dial. 2000;16:182-185
China S. Management of Continuous Ambulatory Peritoneal Dialysis Patients in a Disaster: The Japanese Experience During the Kobe Earthquake. Ren Fail. 1997;19(5): 687-692 https://dx.doi.org/10.3109/08860229709109034
Kenney R. Emergency Preparedness Concepts for Dialysis Facilities: Reawakened after Hurricane Katrina. Clin J Am Soc Nephrol 2007;2: 809–813 https://dx.doi.org/10.2215/CJN.03971106
COVID-19 News and Information. Prama: ERA-EDTA; 2020 [citado diciembre 30 2020].Disponible en https://www.era-edta.org/en/covid-19-news-and-information/#toggle-id-14
International Society of Nephrology (ISN). COVID-19. Brussels: ISN; 2020 [citado diciem-bre 30 2020]. Disponible en: https://www.theisn.org/covid-19
Stenvinkel P, Fouque D, Wanner C. Life/2020—the future of kidney disease. Nephrol DialTransplant. 2020;35(Suppl 2):ii1-3. https://dx.doi.org/10.1093/ndt/gfaa028
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2020 Revista Colombiana de Nefrología